Nuvalent (NUVL) EBITDA (2020 - 2026)

Nuvalent has reported EBITDA for 7 years, with the latest figure at -$113.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 35.04% year-over-year to -$113.0 million; the trailing twelve-month figure through Mar 2026 stood at -$452.3 million (down 51.43% YoY), and the FY2025 full-year result was -$423.0 million, down 62.15% from the prior year.
• EBITDA for Q1 2026 stood at -$113.0 million, up from -$118.7 million in the prior quarter.
• The five-year high for EBITDA was -$18.3 million in Q1 2022, with the low at -$121.4 million in Q3 2025.
• Historically, EBITDA has averaged -$59.1 million across 5 years, with a median of -$45.8 million in 2024.
• Annual changes were most pronounced in 2022 — EBITDA sank 170.3% — and 2026, when it slumped 35.04%.
• Nuvalent's EBITDA stood at -$25.8 million in 2022, then plunged by 43.49% to -$37.0 million in 2023, then plunged by 106.21% to -$76.2 million in 2024, then slumped by 55.81% to -$118.7 million in 2025, then rose by 4.83% to -$113.0 million in 2026.
• The last three EBITDA figures came in at -$113.0 million (Q1 2026), -$118.7 million (Q4 2025), and -$121.4 million (Q3 2025), per Business Quant data.